Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
US7714003B2 · kind B2 · utility
0Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2007 |
| Grant date | May 11, 2010 |
| Priority date | — |
| Expiry date | May 7, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.